CLRBZ
Cellectar Biosciences Inc
Halal Rating :
Last Price
$0.26
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company focused on the development of targeted treatments for cancer. The company's core technology is its proprietary phospholipid drug conjugate™ (PDC) delivery platform, which is designed to provide selective delivery of diverse oncologic payloads to cancer cells and cancer stem cells.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Cellectar Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.